集体诉讼事件概述 - 一家领先的国际证券律师事务所Bleichmar Fonti & Auld LLP宣布，已对Stride公司及其部分高级执行官提起集体诉讼，指控其证券欺诈，原因是公司股价因可能违反联邦证券法而大幅下跌 [1] 诉讼法律细节 - 投资者需在2026年1月12日前向法院申请担任本案首席原告 [3] - 起诉依据是《1934年证券交易法》第10(b)条和第20(a)条，案件正在美国弗吉尼亚东区地方法院审理，案号为MacMahon v. Stride, Inc., et al., No. 1:25-cv-02019 [3] 被指控的欺诈行为 - 公司被指控在相关时期内虚报业务增长和需求，而实际上通过保留“幽灵学生”来虚增入学人数，忽视员工合规要求，并因“糟糕的客户体验”导致更高的退学率和更低的转化率，从而赶走了学生 [4] - 2025年9月14日的一份报告指控公司存在欺诈、欺骗性贸易行为、系统性违法以及故意侵权不当行为，具体指其通过保留“幽灵学生”来获取州政府资金，并忽视对员工的背景调查和执照法等合规要求 [5] 股价下跌详情 - 2025年9月14日的报告导致Stride股价从2025年9月12日的收盘价每股158.36美元下跌18.60美元，跌幅超过11%，至2025年9月15日的每股139.76美元 [5] - 2025年10月28日，公司承认“糟糕的客户体验”导致更高的退学率和更低的转化率，并估计这造成了大约10,000至15,000名入学人数减少，公司因此表示其前景较往年“黯淡” [6] - 此消息导致Stride股价从2025年10月28日的收盘价每股153.53美元下跌83.48美元，跌幅超过54%，至2025年10月29日的每股70.05美元 [6] 公司业务描述 - Stride是一家教育科技公司，为全美学生提供在线学习平台 [4]

NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-acti ...

The average retirement age in the U.S. is 62, according to the 2024 MassMutual Retirement Happiness Study. (1) That’s not a coincidence, but a side effect of bureaucracy. Sixty-two happens to be the earliest age a person is eligible to claim Social Security benefits. Delaying retirement would maximize the size of these benefit checks, although it seems most Americans are keen to quit work as soon as they qualify to receive their first payout. Most of the time, people are urged to hold off for as long a ...

Tilray Brands, Inc. (NASDAQ:TLRY) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Tilray Brands, Inc. (NASDAQ:TLRY) has mixed analyst sentiment, with slightly more than 60% of analysts covering the stock assigning a Hold rating and the remaining 36% recommending buying the stock. While the target price ranges from $8.50 to $25, the median price target of $19 reflects an upside potential of 88.49%. On December 22, Nadine Sarwat, an analyst at Bernstein, reiterated a ‘Market Perf ...

公司评级与目标价变动 - Cantor Fitzgerald 于12月24日对Domo进行覆盖 给予“增持”评级 目标价为22美元 [1] - DA Davidson 于12月5日将Domo目标价从13美元下调至10美元 维持“中性”评级 [3] 公司财务表现与运营状况 - Domo在第三财季（2026财年）收入符合市场一致预期 但账单金额因合作伙伴交易销售周期延长而未达预期 [3] - 公司成立于2010年 总部位于犹他州 运营基于云的现代AI和数据产品平台 [3] - 公司与Altis Consulting建立了战略合作 以提供变革性数据解决方案 [3] 行业并购趋势与公司潜在机会 - 分析师认为Domo可能成为Snowflake或Databricks的收购目标 [2] - 这一观点源于IBM以每股31美元收购Confluent的事件 该交易凸显了实时流处理工作负载对于人工智能和传统数据库迁移的重要性 [2] - 行业可能出现一种趋势 即顶尖数据技术公司将与拥有更广泛分销渠道和互补产品的公司结合 [2]

COMPASS Pathways plc (NASDAQ:CMPS) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, COMPASS Pathways plc (NASDAQ:CMPS) has a ‘Buy’ or equivalent rating from the majority of the analysts covering the stock. With a target price range of $8 to $40, the median price target of $15 translates to an upside potential of 119.14% from the current price. On December 17, Gavin Clark-Gartner, an analyst at Evercore ISI, reaffirmed a ‘Hold’ rating on COMPASS Pathways plc (NASDAQ:CMPS), keepin ...

Cerus Corporation (NASDAQ:CERS) is among the Best Get Rich Fast Stocks to Buy Right Now. On December 23, TheFly reported that TD Cowen views Cerus Corporation (NASDAQ:CERS)’s Intercept Fibrinogen Complex franchise as an “underappreciated” growth engine in the long haul. The firm believes the newly announced BCA partnership will significantly enhance its adoption, scalability, and profitability across the U.S. blood center space. With that said, the financial services firm remains confident in the sustain ...

Absci Corporation (NASDAQ:ABSI) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Absci Corporation (NASDAQ:ABSI) is a consensus buy among all nine analysts covering the stock. The median price target of $9 translates to an upside potential of 150.70%. On December 17, H.C. Wainwright reaffirmed the ‘Buy’ rating on Absci Corporation (NASDAQ:ABSI), while raising the price target to $8 from $7. The price target revision, reflecting an upside potential of 125%, follows the firm’s inc ...

ProKidney Corp. (NASDAQ:PROK) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, ProKidney Corp. (NASDAQ:PROK) has a “buy” rating from slightly more than half of the analysts covering the stock. While the price target ranges from $1 to $12, the median price target of $6.50 reflects an upside potential of 152.92%. Among the analysts bullish on the stock is Joseph Pantginis, an analyst at H.C. Wainwright, who assumed coverage on the company with a ‘Buy’ rating and a $12 price target ...

Atai Beckley N.V. (NASDAQ:ATAI) is among the Best Get Rich Fast Stocks to Buy Right Now. On December 23, Justin Walsh from JonesTrading initiated coverage on Atai Beckley N.V. (NASDAQ:ATAI) with a ‘Buy’ rating and a price target of $16, according to TheFly. This translates to an upside potential of nearly 282%. According to the firm, the company’s psychedelic and empathogenic drugs pipeline presents “differentiated opportunities” across large neuropsychiatric indications. Walsh believes Atai Beckley N.V. ...